Turnstone Biologics Corp.·4

Oct 17, 6:42 PM ET

Ramanan Venkat 4

4 · Turnstone Biologics Corp. · Filed Oct 17, 2023

Insider Transaction Report

Form 4
Period: 2023-10-16
Ramanan Venkat
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2023-10-16+46,60646,606 total
    Exercise: $2.61Exp: 2033-10-15Common Stock (46,606 underlying)
Footnotes (1)
  • [F1]One fourth (1/4th) of the shares subject to the option award shall vest on October 12, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION